欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/6097/001
药品名称Tranexamsäure Baxter 100 mg/ml Injektionslösung/Infusionslösung
活性成分
    • tranexamic acid 100.0 mg
剂型Solution for injection/infusion
上市许可持有人Baxter Holding B.V. Kobaltweg 49 NL-3542 CE Utrecht The Netherlands
参考成员国 - 产品名称Germany (DE)
Tranexamic acid 100 mg/ml Injektionslösung
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Tranexamic acid Baxter 100 mg/ml solution injectable/ pour perfusion
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Tranexamsäure Baxter 100 mg/ml Injektionslösung/Infusionslösung
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Tranexamic acid Baxter
    • Finland (FI)
    • Poland (PL)
      Tranexamic acid Baxter
    • Latvia (LV)
    • Lithuania (LT)
      Tranexamic acid Baxter 100mg/ml injekcinis ar infuzinis tirpalas
    • Estonia (EE)
      TRANEXAMIC ACID BAXTER
    • Hungary (HU)
许可日期2020/04/22
最近更新日期2024/02/26
药物ATC编码
    • B02AA02 tranexamic acid
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase